Plumage and body parts of birds-of-paradise glow in certain areas when viewed under blue and ultraviolet, or UV, light, ...

Picture a primordial Earth: a world of muted browns, greys and greens. Fast forward to today, and Earth teems with a ...

Looking for something to do this weekend? Here are a few recommendations from Globe writers and critics, covering music, ...

Picture a primordial Earth: a world of muted browns, grays and greens. Fast forward to today, and Earth teems with a ...

Blue Bird Corporation (BLBD) recently announced fiscal Q1 results, beating top and bottom-line expectations. While the ...

Blue Bird Corporation is a compelling investment due to its focus on electric school buses and attractive stock valuation despite recent performance setbacks. Read more here.

BLBD remains volatile despite strong earnings, federal funding uncertainties, and revised EV sales guidance. Explore more ...

Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million.

There is a catch. If the private equity firms can boost sales of bluebird’s three gene therapies to $600 million—over any ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

As bluebird bio struggles to get its gene therapies over the finishing line, the company says its financial position raises "substantial doubt" about its ability to continue as a going concern.